Erasure Coding is a data storage technique that enhances fault tolerance by breaking files into chunks and generating additional pieces for reconstruction. This technology, exemplified by systems like Ceph, offers more robust data protection than traditional methods like RAID or replication. Erasure

0 views • 10 slides

ECFA-UK, the European Committee for Future Accelerators, consists of members from prestigious institutions in the UK like Oxford, Edinburgh, Bristol, RAL, Glasgow, Cambridge, and UCL. The committee's main objective is to assess and ensure the well-being of the particle physics field in Europe and en

1 views • 11 slides

This study, named KITE, focused on switching to LPV/r and RAL treatment in HIV patients without virologic failure. The trial included 40 participants continuing triple therapy, with primary endpoints being HIV RNA levels and event-free treatment failure. Results showed high virological response rate

0 views • 6 slides

The comparison between Etravirine (ETR) and Efavirenz (EFV) in the SENSE Study showed differences in neuropsychiatric adverse events, treatment response, and patient characteristics. ETR with 2 NRTIs resulted in fewer drug-related adverse events than EFV with 2 NRTIs. ETR also showed better response

0 views • 7 slides

STAR Study compared the efficacy and safety of RPV/FTC/TDF and EFV/FTC/TDF in treatment-naive HIV patients. The study included 394 participants in each group, assessing HIV RNA suppression rates, CD4 count improvements, treatment responses, and resistance analyses up to 48 weeks. Results showed RPV/

0 views • 15 slides

In the STARTMRK study, Raltegravir (RAL) was compared to Efavirenz (EFV) in combination with TDF/FTC for the treatment of HIV. The study aimed to demonstrate non-inferiority of RAL compared to EFV in achieving HIV RNA levels below 50 c/mL. Baseline characteristics and patient disposition were assess

0 views • 12 slides

David Kelsey from STFC-RAL presented on IPv6 security and threats at the IPv6 workshop pre-GDB at CERN in June 2016. The workshop covered topics such as IPv6 protocol attacks, issues for site network security teams and sys admins, new features of IPv6, security pros and cons, immediate IPv6 concerns

0 views • 29 slides

The comparison study explores NNRTI regimens alongside the DRIVE-AHEAD trial, focusing on DOR/3TC/TDF vs EFV-FTC/TDF. DRIVE-AHEAD assesses the efficacy and safety of DOR in ARV-naïve HIV patients, aiming for non-inferiority based on virologic response, with DOR exhibiting potential neuropsychiatric

0 views • 11 slides